Tetsuya Matoba
Overview
Explore the profile of Tetsuya Matoba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
2112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamasaki H, Arimura H, Yamasaki Y, Yamamoto T, Fukata M, Matoba T, et al.
Phys Eng Sci Med
. 2024 Dec;
PMID: 39739189
This study proposed noninvasive machine-learning models for the detection of lesion-specific ischemia (LSI) in patients with stable angina with intermediate stenosis severity based on coronary computed tomography (CT) angiography. This...
2.
Otsuka Y, Ishii M, Ikebe S, Nakamura T, Tsujita K, Matoba T, et al.
Open Heart
. 2024 Dec;
11(2.
PMID: 39719275
Background: Hypertension is a risk factor for bleeding events and is included in the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly, Drugs/Alcohol concomitantly)score. However,...
3.
Yoshida S, Hayashi H, Kawahara T, Katsuki S, Kimura M, Hino R, et al.
Circ Res
. 2024 Dec;
136(1):26-40.
PMID: 39629565
Background: Myofibroblasts are primary cells involved in chronic response-induced cardiac fibrosis. Fibroblast activation protein (FAP) is a relatively specific marker of activated myofibroblasts and a potential target molecule. This study...
4.
Nishi M, Miyamoto Y, Iwanaga Y, Kanaoka K, Sumita Y, Ishihara M, et al.
Circ J
. 2024 Nov;
PMID: 39566969
Cardiovascular diseases (CVD) have imposed a substantial burden on population health and society. In Japan, the National Plan for the Promotion of Measures Against Cerebrovascular and Cardiovascular Disease, grounded in...
5.
Hitomi Y, Imai Y, Kuwabara M, Oba Y, Kabutoya T, Kario K, et al.
Int J Cardiol Heart Vasc
. 2024 Sep;
54:101507.
PMID: 39314922
Background: Polypharmacy is associated with an increased risk of adverse events due to the higher number of drugs used. This is particularly notable in patients with chronic coronary syndrome (CCS),...
6.
Oba Y, Kabutoya T, Kohro T, Imai Y, Kario K, Sato H, et al.
Hypertens Res
. 2024 Sep;
48(2):632-639.
PMID: 39300294
The Japanese Society of Hypertension have established a blood pressure (BP) target of 130/80 mmHg for patients with coronary artery disease (CAD). We evaluated the data of 8793 CAD patients...
7.
Ikebe S, Ishii M, Otsuka Y, Nakamura T, Tsujita K, Matoba T, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2024 Sep;
22:200304.
PMID: 39280775
[This corrects the article DOI: 10.1016/j.ijcrp.2023.200193.].
8.
Nochioka K, Nakayama M, Akashi N, Matoba T, Kohro T, Oba Y, et al.
Int J Cardiol Heart Vasc
. 2024 Sep;
53:101430.
PMID: 39228973
Background: Limited data exist on the prognostic value of changes in pulse pressure (PP, the difference between systolic and diastolic blood pressure) during hospitalization for patients with coronary artery disease...
9.
Baba I, Matoba T, Katsuki S, Koga J, Kawahara T, Kimura M, et al.
Sci Rep
. 2024 Aug;
14(1):19601.
PMID: 39179643
No abstract available.
10.
Suzuki T, Mizuno A, Yoneoka D, Nakashima T, Matoba T, Node K, et al.
PLoS One
. 2024 Aug;
19(8):e0305577.
PMID: 39178172
Introduction: The left-digit bias (LDB), a numerical-related cognitive bias, not only potentially influences decision-making among the general public but also that of medical practitioners. Few studies have investigated its role...